Plus, news about Astellas, Clover, ElevateBio, Monopar, Idorsia and Neurocrine Biosciences:
Vera Therapeutics plans $300M offering: The California biotech is selling shares after presenting Phase 2b data ...
↧
Trending Articles
More Pages to Explore .....